Venous Thromboembolism in DM1
NCT03141749 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2810
Last updated 2017-05-09
Summary
The risk for venous thromboembolism (VTE) in DM1 and in other inherited myopathies, which can lead to chronic immobilization, are unknown. The purpose of this study is to evaluate incidence of VTE in cohort of patients presenting with DM1 with a comparison to a group of other inheritable myopathies and to a community-based population.
Conditions
- Venous Thromboembolism
- Pulmonary Embolism
- Deep Vein Thrombosis
- Myopathy
- Myotonic Dystrophy 1
Sponsors & Collaborators
-
Institut de Myologie, France
lead OTHER
Principal Investigators
-
Karim Wahbi, MD, PhD · Institut de Myologie, Paris, FRANCE
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2000-01-31
- Primary Completion
- 2014-11-30
- Completion
- 2017-01-31
More Related Trials
-
Research of Biomarkers in Duchenne Muscular Dystrophy Patients
NCT01380964 ·Status: COMPLETED
-
A Registered Cohort Study on Duchenne Muscular Dystrophy
NCT04012671 ·Status: RECRUITING
-
Breathlessness Assessment in Adult Patients With Myotonic Dystrophy Type 1
NCT04835298 ·Status: COMPLETED
-
Characterization of Clinical Skeletal and Cardiac Impairment in Carriers of DMD and BMD
NCT02972580 ·Status: ACTIVE_NOT_RECRUITING
-
DM1 Heart Registry - DM1 Respiratory Registry
NCT01136330 ·Status: COMPLETED
-
Multicenter Observational Study of Myotonic Dystrophy Type 1
NCT02308657 ·Status: COMPLETED
-
Study of Muscle Wasting and Altered Metabolism in Patients With Myotonic Dystrophy
NCT00004769 ·Status: COMPLETED
-
Observational Prolonged Trial in Myotonic Dystrophy Type 1
NCT02118779 ·Status: COMPLETED ·Phase: NA
-
The Safety, Efficacy and Tolerability of Remote Ischemic Preconditioning as a Therapy to DMD
NCT02614820 ·Status: UNKNOWN ·Phase: NA
-
Estimation of Non-Reimbursable Costs for Patients With Duchenne Muscular Dystrophy in France
NCT06861270 ·Status: RECRUITING
-
The Efficacy and Safety of Metoprolol as add-on Treatment to Standard of Care in Preventing Cardiomyopathy in Patients With DMD
NCT05066633 ·Status: RECRUITING ·Phase: PHASE3
-
Clinical Outcome Measures in Myotonic Dystrophy Type 2
NCT03603171 ·Status: COMPLETED
-
Arrhythmias in Myotonic Muscular Dystrophy
NCT00622453 ·Status: COMPLETED
-
Molecular Analysis of Patients With Neuromuscular Disease
NCT00390104 ·Status: RECRUITING
-
Prospective, Longitudinal Study of the Natural History and Functional Status of Patients With Myotubular Myopathy (MTM)
NCT02057705 ·Status: COMPLETED
-
This is a Study to Get More Information About Non Ambulatory Boys & Men With Duchenne Muscular Dystrophy
NCT01098708 ·Status: COMPLETED
-
Non-invasive Imaging of Muscle Structure in Duchenne Muscular Dystrophy Using Multispectral Optoacoustic Tomography
NCT03490214 ·Status: COMPLETED ·Phase: NA
-
phenotypeS in Non Ambulant Duchenne Muscular Dystrophy
NCT06366815 ·Status: RECRUITING
-
Myotubular Myopathy Genetic Testing Study
NCT01817946 ·Status: COMPLETED
-
Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy
NCT05280730 ·Status: COMPLETED
-
Clinical, Biological and NMR Outcome Measures Study for Hereditary Inclusion Body Myopathy Due to Mutation of UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine Kinase Gene (GNE)
NCT02196909 ·Status: COMPLETED ·Phase: NA
-
Study of Eteplirsen in Young Participants With Duchenne Muscular Dystrophy (DMD) Amenable to Exon 51 Skipping
NCT03218995 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Dose Finding Study of NS-065/NCNP-01 in Boys With Duchenne Muscular Dystrophy (DMD)
NCT02740972 ·Status: COMPLETED ·Phase: PHASE2
-
Myotubular Myopathy Event Study
NCT01840657 ·Status: COMPLETED
-
Estab Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
NCT03981575 ·Status: RECRUITING